{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:21:07Z","timestamp":1789395667690,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jconrel.2024.05.040","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T14:11:58Z","timestamp":1716559918000},"page":"111-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Thermosensitive gel-nano system against esophageal cancer via restoring p53 activity and boosting T-cell immunity"],"prefix":"10.1016","volume":"371","author":[{"given":"Ke","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yourong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2024.05.040_bb0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13045-020-00981-4","article-title":"Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea","volume":"13","author":"Yang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.040_bb0010","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S2468-1253(20)30007-8","article-title":"The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"26","key":"10.1016\/j.jconrel.2024.05.040_bb0015","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMra1314530","article-title":"Esophageal carcinoma","volume":"371","author":"Rustgi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.040_bb0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ccell.2022.02.007","article-title":"Toripalimab plus chemotherapy in treatment-na\u00efve, advanced esophageal squamous cell carcinoma (JUPITER-06): a multi-center phase 3 trial","volume":"40","author":"Wang","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.040_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1200\/JCO.2017.74.9846","article-title":"Safety and antitumor activity of the anti-programmed death-1 antibody pembrolizumab in patients with advanced esophageal carcinoma","volume":"36","author":"Doi","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"26","key":"10.1016\/j.jconrel.2024.05.040_bb0030","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.21.01926","article-title":"Tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma (RATIONALE-302): a randomized phase III study","volume":"40","author":"Shen","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"35","key":"10.1016\/j.jconrel.2024.05.040_bb0035","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1200\/JCO.20.01888","article-title":"Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer","volume":"38","author":"Kojima","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.040_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1254\/jphs.14150FP","article-title":"Resistance to cetuximab in EGFR-overexpressing esophageal squamous cell carcinoma xenografts due to FGFR2 amplification and overexpression","volume":"126","author":"Zhang","year":"2014","journal-title":"J. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.040_bb0045","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/cam4.3884","article-title":"BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis","volume":"10","author":"Zhao","year":"2021","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.040_bb0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41419-023-05571-z","article-title":"BACH1-induced ferroptosis drives lymphatic metastasis by repressing the biosynthesis of monounsaturated fatty acids","volume":"14","author":"Xie","year":"2023","journal-title":"Cell Death Dis."},{"issue":"7751","key":"10.1016\/j.jconrel.2024.05.040_bb0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1005-x","article-title":"Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism","volume":"568","author":"Lee","year":"2019","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.040_bb0060","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cell.2019.06.005","article-title":"BACH1 stabilization by antioxidants stimulates lung cancer metastasis","volume":"178","author":"Wiel","year":"2019","journal-title":"Cell."},{"key":"10.1016\/j.jconrel.2024.05.040_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2019.01.003","article-title":"BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition","volume":"445","author":"Han","year":"2019","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.040_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12032-021-01573-z","article-title":"Regulatory mechanisms of heme regulatory protein BACH1: a potential therapeutic target for cancer","volume":"38","author":"Arunachalam","year":"2021","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.040_bb0075","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1038\/s41467-020-20019-0","article-title":"Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment","volume":"11","author":"Zheng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.05.040_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108451","article-title":"BACH1 as a potential target for immunotherapy in glioblastomas","volume":"103","author":"Yuan","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.040_bb0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","article-title":"Drugging p53 in cancer: one protein, many targets","volume":"22","author":"Hassin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.040_bb0090","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41419-022-05408-1","article-title":"Mutant p53 in cancer: from molecular mechanism to therapeutic modulation","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2024.05.040_bb0095","doi-asserted-by":"crossref","first-page":"1141420","DOI":"10.3389\/fphar.2023.1141420","article-title":"Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth","volume":"14","author":"Guan","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.040_bb0100","first-page":"821","article-title":"Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression","volume":"15","author":"Hanazono","year":"2006","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.040_bb0105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/cas.13454","article-title":"PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation","volume":"109","author":"Furukawa","year":"2018","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.040_bb0110","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies","volume":"5","author":"Vargason","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.040_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jare.2013.07.006","article-title":"Hydrogel: preparation, characterization, and applications: a review","volume":"6","author":"Ahmed","year":"2015","journal-title":"J. Adv. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.040_bb0120","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nchem.2629","article-title":"Materials and methods for delivery of biological drugs","volume":"8","author":"Zelikin","year":"2016","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jconrel.2024.05.040_bb0125","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1126\/science.aaf3627","article-title":"Advances in engineering hydrogels","volume":"356","author":"Zhang","year":"2017","journal-title":"Science."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.040_bb0130","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.040_bb0135","doi-asserted-by":"crossref","first-page":"336","DOI":"10.20892\/j.issn.2095-3941.2020.0510","article-title":"Recent progress of nanotechnology-based theranostic systems in cancer treatments","volume":"18","author":"Xue","year":"2021","journal-title":"Cancer Biol. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.040_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.040_bb0145","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1021\/acsnano.5b01433","article-title":"Nanocomposite hydrogels: 3D polymer-nanoparticle synergies for on-demand drug delivery","volume":"9","author":"Merino","year":"2015","journal-title":"ACS Nano"},{"issue":"48","key":"10.1016\/j.jconrel.2024.05.040_bb0150","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1002\/adma.201603632","article-title":"Assembly-induced thermogenesis of gold nanoparticles in the presence of alternating magnetic field for controllable drug release of hydrogel","volume":"28","author":"Wang","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.05.040_bb0155","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.2147\/IJN.S418534","article-title":"Progress in pluronic F127 derivatives for application in wound healing and repair","volume":"18","author":"Li","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.040_bb0160","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1177\/08853282211058099","article-title":"Biomedical applications of tannic acid","volume":"36","author":"Baldwin","year":"2022","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.jconrel.2024.05.040_bb0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijbiomac.2015.10.057","article-title":"Biocompatible and biodegradable poly(tannic acid) hydrogel with antimicrobial and antioxidant properties","volume":"82","author":"Sahiner","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.040_bb0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/10408699891274273","article-title":"Tannins and human health: a review","volume":"38","author":"Chung","year":"1998","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jconrel.2024.05.040_bb0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jconrel.2020.04.042","article-title":"An elastic gel consisting of natural polyphenol and pluronic for simultaneous dura sealing and treatment of spinal cord injury","volume":"323","author":"Wang","year":"2020","journal-title":"J. Control. Release"},{"issue":"47","key":"10.1016\/j.jconrel.2024.05.040_bb0180","doi-asserted-by":"crossref","first-page":"52579","DOI":"10.1021\/acsami.2c11574","article-title":"Decorated polyetheretherketone implants with antibacterial and antioxidative effects through layer-by-layer nanoarchitectonics facilitate diabetic bone integration with infection","volume":"14","author":"Huang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"28","key":"10.1016\/j.jconrel.2024.05.040_bb0185","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1016\/j.biomaterials.2012.06.008","article-title":"cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer","volume":"33","author":"Liu","year":"2012","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2024.05.040_bb0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.040_bb0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1021\/acs.molpharmaceut.0c01089","article-title":"Potential roles of the glass transition temperature of PLGA microparticles in drug release kinetics","volume":"18","author":"Park","year":"2021","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.040_bb0200","first-page":"1878","article-title":"Poly(\u03b1-l-lysine)-based nanomaterials for versatile biomedical applications: current advances and perspectives","volume":"6","author":"Zheng","year":"2021","journal-title":"Bioact Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.040_bb0205","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1034\/j.1399-3011.1999.00052.x","article-title":"Solution stability of linear vs. cyclic RGD peptides","volume":"53","author":"Bogdanowich-Knipp","year":"1999","journal-title":"J. Pept. Res."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.040_bb0210","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1021\/acsnano.9b08693","article-title":"Tumor targeting by \u03b1(v)\u03b2(3)-integrin-specific lipid nanoparticles occurs via phagocyte hitchhiking","volume":"14","author":"Sofias","year":"2020","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.040_bb0215","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s10856-007-3237-9","article-title":"Synthesis and characterization of arginine-glycine-aspartic peptides conjugated poly(lactic acid-co-L-lysine) diblock copolymer","volume":"19","author":"Yu","year":"2008","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"17","key":"10.1016\/j.jconrel.2024.05.040_bb0220","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1016\/j.biomaterials.2012.02.041","article-title":"A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery","volume":"33","author":"Liu","year":"2012","journal-title":"Biomaterials."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.040_bb0225","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted therapy for anticancer treatment","volume":"54","author":"Min","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.040_bb0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.jconrel.2024.05.040_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174178","article-title":"siRNA: mechanism of action, challenges, and therapeutic approaches","volume":"905","author":"Alshaer","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.040_bb0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2022.12.004","article-title":"Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.040_bb0245","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1349-7006.2007.00524.x","article-title":"p53 gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: results in Japan and comparisons with other countries","volume":"98","author":"Egashira","year":"2007","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.040_bb0250","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1074\/jbc.RA118.004671","article-title":"p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells","volume":"294","author":"Rangel","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.05.040_bb0255","first-page":"27(1)","article-title":"Nanostructured lipid carriers-hydrogels system for drug delivery: nanohybrid technology perspective","author":"Syed Azhar","year":"2022","journal-title":"Molecules."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.040_bb0260","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4155\/tde-2019-0010","article-title":"Nanogels as drug-delivery systems: a comprehensive overview","volume":"10","author":"Suhail","year":"2019","journal-title":"Ther. Deliv."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.040_bb0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12929-018-0468-7","article-title":"Tumor xenograft animal models for esophageal squamous cell carcinoma","volume":"25","author":"Lee","year":"2018","journal-title":"J. Biomed. Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.040_bb0270","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.14202\/vetworld.2016.1229-1232","article-title":"Laboratory animal models for esophageal cancer","volume":"9","author":"Nair","year":"2016","journal-title":"Vet World."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.040_bb0275","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1038\/s41467-020-17492-y","article-title":"Single-cell transcriptomic analysis in a mouse model deciphers cell transition states in the multistep development of esophageal cancer[J]","volume":"11","author":"Yao","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T02:09:11Z","timestamp":1719281351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924003249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":55,"alternative-id":["S0168365924003249"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.040","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thermosensitive gel-nano system against esophageal cancer via restoring p53 activity and boosting T-cell immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}